nodes	percent_of_prediction	percent_of_DWPC	metapath
Dipyridamole—SLC29A1—Didanosine—acquired immunodeficiency syndrome	0.302	0.48	CbGbCtD
Dipyridamole—ABCC5—Zidovudine—acquired immunodeficiency syndrome	0.121	0.193	CbGbCtD
Dipyridamole—ABCC4—Zidovudine—acquired immunodeficiency syndrome	0.0583	0.0925	CbGbCtD
Dipyridamole—ABCC4—Lamivudine—acquired immunodeficiency syndrome	0.0451	0.0716	CbGbCtD
Dipyridamole—ABCB1—Lopinavir—acquired immunodeficiency syndrome	0.0172	0.0273	CbGbCtD
Dipyridamole—ABCB1—Amprenavir—acquired immunodeficiency syndrome	0.0156	0.0247	CbGbCtD
Dipyridamole—ABCB1—Indinavir—acquired immunodeficiency syndrome	0.0134	0.0213	CbGbCtD
Dipyridamole—ABCB1—Nelfinavir—acquired immunodeficiency syndrome	0.013	0.0207	CbGbCtD
Dipyridamole—ABCB1—Saquinavir—acquired immunodeficiency syndrome	0.0118	0.0187	CbGbCtD
Dipyridamole—ABCB1—Ritonavir—acquired immunodeficiency syndrome	0.0118	0.0187	CbGbCtD
Dipyridamole—ABCB1—Zidovudine—acquired immunodeficiency syndrome	0.0113	0.0179	CbGbCtD
Dipyridamole—ABCB1—Lamivudine—acquired immunodeficiency syndrome	0.00875	0.0139	CbGbCtD
Dipyridamole—PDE6A—retina—acquired immunodeficiency syndrome	0.00379	0.0327	CbGeAlD
Dipyridamole—PDE6C—retina—acquired immunodeficiency syndrome	0.00359	0.031	CbGeAlD
Dipyridamole—PDE6B—retina—acquired immunodeficiency syndrome	0.00228	0.0197	CbGeAlD
Dipyridamole—PDE6H—retina—acquired immunodeficiency syndrome	0.00212	0.0183	CbGeAlD
Dipyridamole—PDE6G—retina—acquired immunodeficiency syndrome	0.00204	0.0176	CbGeAlD
Dipyridamole—PDE5A—endothelium—acquired immunodeficiency syndrome	0.00166	0.0143	CbGeAlD
Dipyridamole—PDE6B—lymphoid tissue—acquired immunodeficiency syndrome	0.00162	0.014	CbGeAlD
Dipyridamole—PDE1C—lung—acquired immunodeficiency syndrome	0.00156	0.0135	CbGeAlD
Dipyridamole—PDE6D—blood—acquired immunodeficiency syndrome	0.00155	0.0134	CbGeAlD
Dipyridamole—PDE6B—blood—acquired immunodeficiency syndrome	0.00152	0.0132	CbGeAlD
Dipyridamole—PDE6D—bone marrow—acquired immunodeficiency syndrome	0.0015	0.0129	CbGeAlD
Dipyridamole—PDE5A—blood plasma—acquired immunodeficiency syndrome	0.00147	0.0127	CbGeAlD
Dipyridamole—PDE6B—spinal cord—acquired immunodeficiency syndrome	0.00147	0.0127	CbGeAlD
Dipyridamole—PDE1C—nervous system—acquired immunodeficiency syndrome	0.00144	0.0125	CbGeAlD
Dipyridamole—PDE6D—vagina—acquired immunodeficiency syndrome	0.00144	0.0124	CbGeAlD
Dipyridamole—PDE3A—blood plasma—acquired immunodeficiency syndrome	0.00143	0.0124	CbGeAlD
Dipyridamole—PDE6B—vagina—acquired immunodeficiency syndrome	0.00141	0.0122	CbGeAlD
Dipyridamole—PRUNE—lung—acquired immunodeficiency syndrome	0.00141	0.0121	CbGeAlD
Dipyridamole—PDE1C—central nervous system—acquired immunodeficiency syndrome	0.00139	0.012	CbGeAlD
Dipyridamole—PDE6G—blood—acquired immunodeficiency syndrome	0.00136	0.0118	CbGeAlD
Dipyridamole—PDE6D—lung—acquired immunodeficiency syndrome	0.00136	0.0117	CbGeAlD
Dipyridamole—PDE7A—lymphoid tissue—acquired immunodeficiency syndrome	0.00134	0.0116	CbGeAlD
Dipyridamole—PDE6B—lung—acquired immunodeficiency syndrome	0.00134	0.0115	CbGeAlD
Dipyridamole—PDE6B—nervous system—acquired immunodeficiency syndrome	0.00124	0.0107	CbGeAlD
Dipyridamole—PDE6G—lung—acquired immunodeficiency syndrome	0.0012	0.0103	CbGeAlD
Dipyridamole—PDE6B—central nervous system—acquired immunodeficiency syndrome	0.00119	0.0103	CbGeAlD
Dipyridamole—PDE6H—nervous system—acquired immunodeficiency syndrome	0.00115	0.00993	CbGeAlD
Dipyridamole—PDE6H—central nervous system—acquired immunodeficiency syndrome	0.00111	0.00956	CbGeAlD
Dipyridamole—PDE1C—brain—acquired immunodeficiency syndrome	0.0011	0.00952	CbGeAlD
Dipyridamole—PDE1C—lymph node—acquired immunodeficiency syndrome	0.00107	0.0092	CbGeAlD
Dipyridamole—PDE7A—nervous system—acquired immunodeficiency syndrome	0.00102	0.00885	CbGeAlD
Dipyridamole—PRUNE—brain—acquired immunodeficiency syndrome	0.000995	0.00859	CbGeAlD
Dipyridamole—PDE7A—central nervous system—acquired immunodeficiency syndrome	0.000987	0.00852	CbGeAlD
Dipyridamole—PDE7B—lung—acquired immunodeficiency syndrome	0.000967	0.00835	CbGeAlD
Dipyridamole—PDE10A—digestive system—acquired immunodeficiency syndrome	0.000967	0.00835	CbGeAlD
Dipyridamole—PRUNE—lymph node—acquired immunodeficiency syndrome	0.000961	0.0083	CbGeAlD
Dipyridamole—PDE6D—brain—acquired immunodeficiency syndrome	0.000961	0.0083	CbGeAlD
Dipyridamole—PDE6B—brain—acquired immunodeficiency syndrome	0.000945	0.00816	CbGeAlD
Dipyridamole—ABCC4—blood plasma—acquired immunodeficiency syndrome	0.000933	0.00805	CbGeAlD
Dipyridamole—PDE6D—lymph node—acquired immunodeficiency syndrome	0.000928	0.00802	CbGeAlD
Dipyridamole—PDE2A—blood—acquired immunodeficiency syndrome	0.000921	0.00795	CbGeAlD
Dipyridamole—PDE1B—blood—acquired immunodeficiency syndrome	0.000913	0.00788	CbGeAlD
Dipyridamole—PDE7B—nervous system—acquired immunodeficiency syndrome	0.000896	0.00773	CbGeAlD
Dipyridamole—PDE2A—spinal cord—acquired immunodeficiency syndrome	0.000887	0.00766	CbGeAlD
Dipyridamole—PDE11A—brain—acquired immunodeficiency syndrome	0.000879	0.00759	CbGeAlD
Dipyridamole—PDE6H—brain—acquired immunodeficiency syndrome	0.000879	0.00759	CbGeAlD
Dipyridamole—PDE7B—central nervous system—acquired immunodeficiency syndrome	0.000862	0.00745	CbGeAlD
Dipyridamole—PDE3B—blood—acquired immunodeficiency syndrome	0.000858	0.00741	CbGeAlD
Dipyridamole—PDE2A—vagina—acquired immunodeficiency syndrome	0.000854	0.00737	CbGeAlD
Dipyridamole—PDE3B—bone marrow—acquired immunodeficiency syndrome	0.00083	0.00717	CbGeAlD
Dipyridamole—PDE6G—lymph node—acquired immunodeficiency syndrome	0.000817	0.00706	CbGeAlD
Dipyridamole—PDE8B—vagina—acquired immunodeficiency syndrome	0.000814	0.00703	CbGeAlD
Dipyridamole—PDE10A—lung—acquired immunodeficiency syndrome	0.000807	0.00697	CbGeAlD
Dipyridamole—PDE2A—lung—acquired immunodeficiency syndrome	0.000807	0.00697	CbGeAlD
Dipyridamole—PDE5A—retina—acquired immunodeficiency syndrome	0.000806	0.00696	CbGeAlD
Dipyridamole—PDE8A—blood—acquired immunodeficiency syndrome	0.00079	0.00682	CbGeAlD
Dipyridamole—PDE7A—brain—acquired immunodeficiency syndrome	0.000783	0.00676	CbGeAlD
Dipyridamole—PDE8B—lung—acquired immunodeficiency syndrome	0.00077	0.00665	CbGeAlD
Dipyridamole—PDE8A—spinal cord—acquired immunodeficiency syndrome	0.000761	0.00657	CbGeAlD
Dipyridamole—PDE3B—lung—acquired immunodeficiency syndrome	0.000752	0.0065	CbGeAlD
Dipyridamole—PDE10A—nervous system—acquired immunodeficiency syndrome	0.000748	0.00646	CbGeAlD
Dipyridamole—PDE2A—nervous system—acquired immunodeficiency syndrome	0.000748	0.00646	CbGeAlD
Dipyridamole—PDE1B—nervous system—acquired immunodeficiency syndrome	0.000741	0.0064	CbGeAlD
Dipyridamole—PDE1A—spinal cord—acquired immunodeficiency syndrome	0.000737	0.00636	CbGeAlD
Dipyridamole—ABCC5—retina—acquired immunodeficiency syndrome	0.000737	0.00636	CbGeAlD
Dipyridamole—PDE8A—vagina—acquired immunodeficiency syndrome	0.000733	0.00633	CbGeAlD
Dipyridamole—PDE2A—central nervous system—acquired immunodeficiency syndrome	0.00072	0.00621	CbGeAlD
Dipyridamole—PDE10A—central nervous system—acquired immunodeficiency syndrome	0.00072	0.00621	CbGeAlD
Dipyridamole—PDE1B—central nervous system—acquired immunodeficiency syndrome	0.000713	0.00616	CbGeAlD
Dipyridamole—PDE8B—nervous system—acquired immunodeficiency syndrome	0.000713	0.00616	CbGeAlD
Dipyridamole—PDE8A—lung—acquired immunodeficiency syndrome	0.000693	0.00598	CbGeAlD
Dipyridamole—ADA—lymphoid tissue—acquired immunodeficiency syndrome	0.000691	0.00597	CbGeAlD
Dipyridamole—PDE8B—central nervous system—acquired immunodeficiency syndrome	0.000687	0.00593	CbGeAlD
Dipyridamole—PDE7B—brain—acquired immunodeficiency syndrome	0.000685	0.00591	CbGeAlD
Dipyridamole—ADA—digestive system—acquired immunodeficiency syndrome	0.000683	0.00589	CbGeAlD
Dipyridamole—PDE1A—lung—acquired immunodeficiency syndrome	0.00067	0.00579	CbGeAlD
Dipyridamole—PDE7B—lymph node—acquired immunodeficiency syndrome	0.000662	0.00571	CbGeAlD
Dipyridamole—ADA—blood—acquired immunodeficiency syndrome	0.00065	0.00562	CbGeAlD
Dipyridamole—ADA—bone marrow—acquired immunodeficiency syndrome	0.000629	0.00543	CbGeAlD
Dipyridamole—PDE1A—nervous system—acquired immunodeficiency syndrome	0.000621	0.00536	CbGeAlD
Dipyridamole—ADA—vagina—acquired immunodeficiency syndrome	0.000603	0.00521	CbGeAlD
Dipyridamole—PDE1A—central nervous system—acquired immunodeficiency syndrome	0.000598	0.00516	CbGeAlD
Dipyridamole—PDE2A—brain—acquired immunodeficiency syndrome	0.000571	0.00493	CbGeAlD
Dipyridamole—PDE10A—brain—acquired immunodeficiency syndrome	0.000571	0.00493	CbGeAlD
Dipyridamole—ADA—lung—acquired immunodeficiency syndrome	0.00057	0.00492	CbGeAlD
Dipyridamole—PDE1B—brain—acquired immunodeficiency syndrome	0.000566	0.00489	CbGeAlD
Dipyridamole—PDE5A—digestive system—acquired immunodeficiency syndrome	0.000566	0.00488	CbGeAlD
Dipyridamole—PDE4A—lung—acquired immunodeficiency syndrome	0.000556	0.0048	CbGeAlD
Dipyridamole—PDE2A—lymph node—acquired immunodeficiency syndrome	0.000552	0.00477	CbGeAlD
Dipyridamole—PDE10A—lymph node—acquired immunodeficiency syndrome	0.000552	0.00477	CbGeAlD
Dipyridamole—PDE1B—lymph node—acquired immunodeficiency syndrome	0.000547	0.00472	CbGeAlD
Dipyridamole—PDE8B—brain—acquired immunodeficiency syndrome	0.000545	0.00471	CbGeAlD
Dipyridamole—PDE5A—blood—acquired immunodeficiency syndrome	0.000539	0.00465	CbGeAlD
Dipyridamole—PDE3B—brain—acquired immunodeficiency syndrome	0.000532	0.0046	CbGeAlD
Dipyridamole—ADA—nervous system—acquired immunodeficiency syndrome	0.000528	0.00456	CbGeAlD
Dipyridamole—PDE8B—lymph node—acquired immunodeficiency syndrome	0.000527	0.00455	CbGeAlD
Dipyridamole—PDE3A—blood—acquired immunodeficiency syndrome	0.000524	0.00453	CbGeAlD
Dipyridamole—PDE3B—lymph node—acquired immunodeficiency syndrome	0.000514	0.00444	CbGeAlD
Dipyridamole—ADA—central nervous system—acquired immunodeficiency syndrome	0.000508	0.00439	CbGeAlD
Dipyridamole—PDE5A—vagina—acquired immunodeficiency syndrome	0.000499	0.00431	CbGeAlD
Dipyridamole—PDE8A—brain—acquired immunodeficiency syndrome	0.00049	0.00423	CbGeAlD
Dipyridamole—SLC29A1—lymphoid tissue—acquired immunodeficiency syndrome	0.000481	0.00415	CbGeAlD
Dipyridamole—ABCC5—bone marrow—acquired immunodeficiency syndrome	0.000477	0.00412	CbGeAlD
Dipyridamole—SLC29A1—digestive system—acquired immunodeficiency syndrome	0.000475	0.0041	CbGeAlD
Dipyridamole—PDE1A—brain—acquired immunodeficiency syndrome	0.000475	0.0041	CbGeAlD
Dipyridamole—PDE8A—lymph node—acquired immunodeficiency syndrome	0.000474	0.00409	CbGeAlD
Dipyridamole—PDE5A—lung—acquired immunodeficiency syndrome	0.000472	0.00408	CbGeAlD
Dipyridamole—PDE3A—lung—acquired immunodeficiency syndrome	0.00046	0.00397	CbGeAlD
Dipyridamole—PDE1A—lymph node—acquired immunodeficiency syndrome	0.000459	0.00396	CbGeAlD
Dipyridamole—ABCC5—vagina—acquired immunodeficiency syndrome	0.000457	0.00394	CbGeAlD
Dipyridamole—SLC29A1—blood—acquired immunodeficiency syndrome	0.000452	0.00391	CbGeAlD
Dipyridamole—SLC29A1—bone marrow—acquired immunodeficiency syndrome	0.000438	0.00378	CbGeAlD
Dipyridamole—PDE5A—nervous system—acquired immunodeficiency syndrome	0.000437	0.00378	CbGeAlD
Dipyridamole—ABCC5—lung—acquired immunodeficiency syndrome	0.000432	0.00373	CbGeAlD
Dipyridamole—PDE5A—central nervous system—acquired immunodeficiency syndrome	0.000421	0.00364	CbGeAlD
Dipyridamole—SLC29A1—vagina—acquired immunodeficiency syndrome	0.000419	0.00362	CbGeAlD
Dipyridamole—ADA—brain—acquired immunodeficiency syndrome	0.000404	0.00348	CbGeAlD
Dipyridamole—SLC29A1—lung—acquired immunodeficiency syndrome	0.000397	0.00343	CbGeAlD
Dipyridamole—PDE4A—brain—acquired immunodeficiency syndrome	0.000393	0.0034	CbGeAlD
Dipyridamole—ADA—lymph node—acquired immunodeficiency syndrome	0.00039	0.00337	CbGeAlD
Dipyridamole—PDE4A—lymph node—acquired immunodeficiency syndrome	0.00038	0.00328	CbGeAlD
Dipyridamole—SLC29A1—nervous system—acquired immunodeficiency syndrome	0.000367	0.00317	CbGeAlD
Dipyridamole—ABCC4—digestive system—acquired immunodeficiency syndrome	0.000359	0.0031	CbGeAlD
Dipyridamole—SLC29A1—central nervous system—acquired immunodeficiency syndrome	0.000354	0.00305	CbGeAlD
Dipyridamole—ABCC4—blood—acquired immunodeficiency syndrome	0.000342	0.00295	CbGeAlD
Dipyridamole—PDE5A—brain—acquired immunodeficiency syndrome	0.000334	0.00289	CbGeAlD
Dipyridamole—ABCC4—bone marrow—acquired immunodeficiency syndrome	0.000331	0.00285	CbGeAlD
Dipyridamole—PDE3A—brain—acquired immunodeficiency syndrome	0.000325	0.00281	CbGeAlD
Dipyridamole—ABCB1—blood plasma—acquired immunodeficiency syndrome	0.000325	0.0028	CbGeAlD
Dipyridamole—PDE5A—lymph node—acquired immunodeficiency syndrome	0.000323	0.00279	CbGeAlD
Dipyridamole—PDE3A—lymph node—acquired immunodeficiency syndrome	0.000314	0.00271	CbGeAlD
Dipyridamole—ABCC5—brain—acquired immunodeficiency syndrome	0.000306	0.00264	CbGeAlD
Dipyridamole—ABCC4—lung—acquired immunodeficiency syndrome	0.000299	0.00259	CbGeAlD
Dipyridamole—ABCC5—lymph node—acquired immunodeficiency syndrome	0.000295	0.00255	CbGeAlD
Dipyridamole—SLC29A1—brain—acquired immunodeficiency syndrome	0.000281	0.00242	CbGeAlD
Dipyridamole—ABCC4—nervous system—acquired immunodeficiency syndrome	0.000277	0.00239	CbGeAlD
Dipyridamole—SLC29A1—lymph node—acquired immunodeficiency syndrome	0.000271	0.00234	CbGeAlD
Dipyridamole—ABCC4—central nervous system—acquired immunodeficiency syndrome	0.000267	0.00231	CbGeAlD
Dipyridamole—ABCC4—brain—acquired immunodeficiency syndrome	0.000212	0.00183	CbGeAlD
Dipyridamole—ABCC4—lymph node—acquired immunodeficiency syndrome	0.000205	0.00177	CbGeAlD
Dipyridamole—Hypersensitivity—Abacavir—acquired immunodeficiency syndrome	0.00019	0.000935	CcSEcCtD
Dipyridamole—Dermatitis—Didanosine—acquired immunodeficiency syndrome	0.00019	0.000935	CcSEcCtD
Dipyridamole—Cough—Ritonavir—acquired immunodeficiency syndrome	0.000189	0.000931	CcSEcCtD
Dipyridamole—Headache—Didanosine—acquired immunodeficiency syndrome	0.000189	0.00093	CcSEcCtD
Dipyridamole—Dyspnoea—Indinavir—acquired immunodeficiency syndrome	0.000189	0.000929	CcSEcCtD
Dipyridamole—Asthenia—Nelfinavir—acquired immunodeficiency syndrome	0.000188	0.000928	CcSEcCtD
Dipyridamole—Shock—Delavirdine—acquired immunodeficiency syndrome	0.000188	0.000927	CcSEcCtD
Dipyridamole—Malaise—Saquinavir—acquired immunodeficiency syndrome	0.000188	0.000926	CcSEcCtD
Dipyridamole—Somnolence—Indinavir—acquired immunodeficiency syndrome	0.000188	0.000926	CcSEcCtD
Dipyridamole—Asthenia—Stavudine—acquired immunodeficiency syndrome	0.000188	0.000925	CcSEcCtD
Dipyridamole—Convulsion—Ritonavir—acquired immunodeficiency syndrome	0.000188	0.000925	CcSEcCtD
Dipyridamole—Feeling abnormal—Zidovudine—acquired immunodeficiency syndrome	0.000187	0.000923	CcSEcCtD
Dipyridamole—Vertigo—Saquinavir—acquired immunodeficiency syndrome	0.000187	0.000923	CcSEcCtD
Dipyridamole—Thrombocytopenia—Delavirdine—acquired immunodeficiency syndrome	0.000187	0.000922	CcSEcCtD
Dipyridamole—Hypertension—Ritonavir—acquired immunodeficiency syndrome	0.000187	0.000921	CcSEcCtD
Dipyridamole—Syncope—Saquinavir—acquired immunodeficiency syndrome	0.000187	0.000921	CcSEcCtD
Dipyridamole—Tachycardia—Delavirdine—acquired immunodeficiency syndrome	0.000187	0.000919	CcSEcCtD
Dipyridamole—Tremor—Lamivudine—acquired immunodeficiency syndrome	0.000186	0.000918	CcSEcCtD
Dipyridamole—Dyspepsia—Indinavir—acquired immunodeficiency syndrome	0.000186	0.000917	CcSEcCtD
Dipyridamole—Gastrointestinal pain—Zidovudine—acquired immunodeficiency syndrome	0.000186	0.000916	CcSEcCtD
Dipyridamole—Skin disorder—Delavirdine—acquired immunodeficiency syndrome	0.000186	0.000915	CcSEcCtD
Dipyridamole—Pruritus—Nelfinavir—acquired immunodeficiency syndrome	0.000186	0.000915	CcSEcCtD
Dipyridamole—Diarrhoea—Nevirapine—acquired immunodeficiency syndrome	0.000185	0.000913	CcSEcCtD
Dipyridamole—Pruritus—Stavudine—acquired immunodeficiency syndrome	0.000185	0.000912	CcSEcCtD
Dipyridamole—Asthenia—Abacavir—acquired immunodeficiency syndrome	0.000185	0.000911	CcSEcCtD
Dipyridamole—Hyperhidrosis—Delavirdine—acquired immunodeficiency syndrome	0.000185	0.00091	CcSEcCtD
Dipyridamole—Ill-defined disorder—Lamivudine—acquired immunodeficiency syndrome	0.000185	0.000909	CcSEcCtD
Dipyridamole—Myalgia—Ritonavir—acquired immunodeficiency syndrome	0.000185	0.000909	CcSEcCtD
Dipyridamole—Chest pain—Ritonavir—acquired immunodeficiency syndrome	0.000185	0.000909	CcSEcCtD
Dipyridamole—Arthralgia—Ritonavir—acquired immunodeficiency syndrome	0.000185	0.000909	CcSEcCtD
Dipyridamole—Anaemia—Lamivudine—acquired immunodeficiency syndrome	0.000184	0.000906	CcSEcCtD
Dipyridamole—Anxiety—Ritonavir—acquired immunodeficiency syndrome	0.000184	0.000905	CcSEcCtD
Dipyridamole—Loss of consciousness—Saquinavir—acquired immunodeficiency syndrome	0.000183	0.000903	CcSEcCtD
Dipyridamole—Unspecified disorder of skin and subcutaneous tissue—Ritonavir—acquired immunodeficiency syndrome	0.000183	0.000902	CcSEcCtD
Dipyridamole—Gastrointestinal disorder—Indinavir—acquired immunodeficiency syndrome	0.000183	0.000899	CcSEcCtD
Dipyridamole—Pruritus—Abacavir—acquired immunodeficiency syndrome	0.000182	0.000898	CcSEcCtD
Dipyridamole—Fatigue—Indinavir—acquired immunodeficiency syndrome	0.000182	0.000898	CcSEcCtD
Dipyridamole—Discomfort—Ritonavir—acquired immunodeficiency syndrome	0.000182	0.000898	CcSEcCtD
Dipyridamole—Musculoskeletal discomfort—Efavirenz—acquired immunodeficiency syndrome	0.000182	0.000897	CcSEcCtD
Dipyridamole—Cough—Saquinavir—acquired immunodeficiency syndrome	0.000182	0.000896	CcSEcCtD
Dipyridamole—Angioedema—Lamivudine—acquired immunodeficiency syndrome	0.000182	0.000895	CcSEcCtD
Dipyridamole—Pain—Indinavir—acquired immunodeficiency syndrome	0.000181	0.000891	CcSEcCtD
Dipyridamole—Urticaria—Zidovudine—acquired immunodeficiency syndrome	0.000181	0.00089	CcSEcCtD
Dipyridamole—Convulsion—Saquinavir—acquired immunodeficiency syndrome	0.000181	0.00089	CcSEcCtD
Dipyridamole—Dry mouth—Ritonavir—acquired immunodeficiency syndrome	0.00018	0.000889	CcSEcCtD
Dipyridamole—Hypertension—Saquinavir—acquired immunodeficiency syndrome	0.00018	0.000887	CcSEcCtD
Dipyridamole—Abdominal pain—Zidovudine—acquired immunodeficiency syndrome	0.00018	0.000886	CcSEcCtD
Dipyridamole—Diarrhoea—Nelfinavir—acquired immunodeficiency syndrome	0.00018	0.000885	CcSEcCtD
Dipyridamole—Paraesthesia—Efavirenz—acquired immunodeficiency syndrome	0.00018	0.000884	CcSEcCtD
Dipyridamole—Malaise—Lamivudine—acquired immunodeficiency syndrome	0.000179	0.000884	CcSEcCtD
Dipyridamole—Diarrhoea—Stavudine—acquired immunodeficiency syndrome	0.000179	0.000882	CcSEcCtD
Dipyridamole—Nausea—Didanosine—acquired immunodeficiency syndrome	0.000179	0.000882	CcSEcCtD
Dipyridamole—Vertigo—Lamivudine—acquired immunodeficiency syndrome	0.000179	0.00088	CcSEcCtD
Dipyridamole—Hypotension—Delavirdine—acquired immunodeficiency syndrome	0.000179	0.00088	CcSEcCtD
Dipyridamole—Syncope—Lamivudine—acquired immunodeficiency syndrome	0.000178	0.000879	CcSEcCtD
Dipyridamole—Dyspnoea—Efavirenz—acquired immunodeficiency syndrome	0.000178	0.000878	CcSEcCtD
Dipyridamole—ABCB1—retina—acquired immunodeficiency syndrome	0.000178	0.00153	CbGeAlD
Dipyridamole—Somnolence—Efavirenz—acquired immunodeficiency syndrome	0.000178	0.000875	CcSEcCtD
Dipyridamole—Myalgia—Saquinavir—acquired immunodeficiency syndrome	0.000178	0.000874	CcSEcCtD
Dipyridamole—Arthralgia—Saquinavir—acquired immunodeficiency syndrome	0.000178	0.000874	CcSEcCtD
Dipyridamole—Chest pain—Saquinavir—acquired immunodeficiency syndrome	0.000178	0.000874	CcSEcCtD
Dipyridamole—Anxiety—Saquinavir—acquired immunodeficiency syndrome	0.000177	0.000871	CcSEcCtD
Dipyridamole—Oedema—Ritonavir—acquired immunodeficiency syndrome	0.000177	0.000871	CcSEcCtD
Dipyridamole—Diarrhoea—Abacavir—acquired immunodeficiency syndrome	0.000176	0.000869	CcSEcCtD
Dipyridamole—Unspecified disorder of skin and subcutaneous tissue—Saquinavir—acquired immunodeficiency syndrome	0.000176	0.000868	CcSEcCtD
Dipyridamole—Dyspepsia—Efavirenz—acquired immunodeficiency syndrome	0.000176	0.000866	CcSEcCtD
Dipyridamole—Discomfort—Saquinavir—acquired immunodeficiency syndrome	0.000175	0.000864	CcSEcCtD
Dipyridamole—Loss of consciousness—Lamivudine—acquired immunodeficiency syndrome	0.000175	0.000861	CcSEcCtD
Dipyridamole—Feeling abnormal—Indinavir—acquired immunodeficiency syndrome	0.000174	0.000859	CcSEcCtD
Dipyridamole—Musculoskeletal discomfort—Delavirdine—acquired immunodeficiency syndrome	0.000174	0.000858	CcSEcCtD
Dipyridamole—Shock—Ritonavir—acquired immunodeficiency syndrome	0.000174	0.000857	CcSEcCtD
Dipyridamole—Dry mouth—Saquinavir—acquired immunodeficiency syndrome	0.000174	0.000855	CcSEcCtD
Dipyridamole—Cough—Lamivudine—acquired immunodeficiency syndrome	0.000174	0.000855	CcSEcCtD
Dipyridamole—Dizziness—Nelfinavir—acquired immunodeficiency syndrome	0.000174	0.000855	CcSEcCtD
Dipyridamole—Nervous system disorder—Ritonavir—acquired immunodeficiency syndrome	0.000173	0.000854	CcSEcCtD
Dipyridamole—Thrombocytopenia—Ritonavir—acquired immunodeficiency syndrome	0.000173	0.000853	CcSEcCtD
Dipyridamole—Dizziness—Stavudine—acquired immunodeficiency syndrome	0.000173	0.000852	CcSEcCtD
Dipyridamole—Gastrointestinal pain—Indinavir—acquired immunodeficiency syndrome	0.000173	0.000852	CcSEcCtD
Dipyridamole—Tachycardia—Ritonavir—acquired immunodeficiency syndrome	0.000173	0.00085	CcSEcCtD
Dipyridamole—Gastrointestinal disorder—Efavirenz—acquired immunodeficiency syndrome	0.000173	0.00085	CcSEcCtD
Dipyridamole—Convulsion—Lamivudine—acquired immunodeficiency syndrome	0.000172	0.000849	CcSEcCtD
Dipyridamole—Vomiting—Nevirapine—acquired immunodeficiency syndrome	0.000172	0.000849	CcSEcCtD
Dipyridamole—Fatigue—Efavirenz—acquired immunodeficiency syndrome	0.000172	0.000849	CcSEcCtD
Dipyridamole—Skin disorder—Ritonavir—acquired immunodeficiency syndrome	0.000172	0.000846	CcSEcCtD
Dipyridamole—Paraesthesia—Delavirdine—acquired immunodeficiency syndrome	0.000172	0.000846	CcSEcCtD
Dipyridamole—Hyperhidrosis—Ritonavir—acquired immunodeficiency syndrome	0.000171	0.000842	CcSEcCtD
Dipyridamole—Pain—Efavirenz—acquired immunodeficiency syndrome	0.000171	0.000842	CcSEcCtD
Dipyridamole—Rash—Nevirapine—acquired immunodeficiency syndrome	0.000171	0.000842	CcSEcCtD
Dipyridamole—Dermatitis—Nevirapine—acquired immunodeficiency syndrome	0.000171	0.000841	CcSEcCtD
Dipyridamole—Dyspnoea—Delavirdine—acquired immunodeficiency syndrome	0.000171	0.00084	CcSEcCtD
Dipyridamole—Dizziness—Abacavir—acquired immunodeficiency syndrome	0.000171	0.00084	CcSEcCtD
Dipyridamole—Oedema—Saquinavir—acquired immunodeficiency syndrome	0.00017	0.000838	CcSEcCtD
Dipyridamole—Somnolence—Delavirdine—acquired immunodeficiency syndrome	0.00017	0.000837	CcSEcCtD
Dipyridamole—Headache—Nevirapine—acquired immunodeficiency syndrome	0.00017	0.000836	CcSEcCtD
Dipyridamole—Chest pain—Lamivudine—acquired immunodeficiency syndrome	0.000169	0.000834	CcSEcCtD
Dipyridamole—Arthralgia—Lamivudine—acquired immunodeficiency syndrome	0.000169	0.000834	CcSEcCtD
Dipyridamole—Myalgia—Lamivudine—acquired immunodeficiency syndrome	0.000169	0.000834	CcSEcCtD
Dipyridamole—Anxiety—Lamivudine—acquired immunodeficiency syndrome	0.000169	0.000831	CcSEcCtD
Dipyridamole—Dyspepsia—Delavirdine—acquired immunodeficiency syndrome	0.000168	0.000829	CcSEcCtD
Dipyridamole—Unspecified disorder of skin and subcutaneous tissue—Lamivudine—acquired immunodeficiency syndrome	0.000168	0.000828	CcSEcCtD
Dipyridamole—Urticaria—Indinavir—acquired immunodeficiency syndrome	0.000168	0.000828	CcSEcCtD
Dipyridamole—Shock—Saquinavir—acquired immunodeficiency syndrome	0.000167	0.000825	CcSEcCtD
Dipyridamole—Discomfort—Lamivudine—acquired immunodeficiency syndrome	0.000167	0.000824	CcSEcCtD
Dipyridamole—Abdominal pain—Indinavir—acquired immunodeficiency syndrome	0.000167	0.000824	CcSEcCtD
Dipyridamole—Nervous system disorder—Saquinavir—acquired immunodeficiency syndrome	0.000167	0.000822	CcSEcCtD
Dipyridamole—Vomiting—Nelfinavir—acquired immunodeficiency syndrome	0.000167	0.000822	CcSEcCtD
Dipyridamole—Thrombocytopenia—Saquinavir—acquired immunodeficiency syndrome	0.000167	0.000821	CcSEcCtD
Dipyridamole—Vomiting—Stavudine—acquired immunodeficiency syndrome	0.000166	0.000819	CcSEcCtD
Dipyridamole—Dry mouth—Lamivudine—acquired immunodeficiency syndrome	0.000166	0.000816	CcSEcCtD
Dipyridamole—Rash—Nelfinavir—acquired immunodeficiency syndrome	0.000166	0.000815	CcSEcCtD
Dipyridamole—Dermatitis—Nelfinavir—acquired immunodeficiency syndrome	0.000165	0.000814	CcSEcCtD
Dipyridamole—Skin disorder—Saquinavir—acquired immunodeficiency syndrome	0.000165	0.000814	CcSEcCtD
Dipyridamole—Hypotension—Ritonavir—acquired immunodeficiency syndrome	0.000165	0.000814	CcSEcCtD
Dipyridamole—Gastrointestinal disorder—Delavirdine—acquired immunodeficiency syndrome	0.000165	0.000813	CcSEcCtD
Dipyridamole—Rash—Stavudine—acquired immunodeficiency syndrome	0.000165	0.000813	CcSEcCtD
Dipyridamole—Fatigue—Delavirdine—acquired immunodeficiency syndrome	0.000165	0.000812	CcSEcCtD
Dipyridamole—Dermatitis—Stavudine—acquired immunodeficiency syndrome	0.000165	0.000812	CcSEcCtD
Dipyridamole—Feeling abnormal—Efavirenz—acquired immunodeficiency syndrome	0.000165	0.000811	CcSEcCtD
Dipyridamole—Hyperhidrosis—Saquinavir—acquired immunodeficiency syndrome	0.000165	0.00081	CcSEcCtD
Dipyridamole—Headache—Nelfinavir—acquired immunodeficiency syndrome	0.000164	0.00081	CcSEcCtD
Dipyridamole—Headache—Stavudine—acquired immunodeficiency syndrome	0.000164	0.000807	CcSEcCtD
Dipyridamole—Vomiting—Abacavir—acquired immunodeficiency syndrome	0.000164	0.000807	CcSEcCtD
Dipyridamole—Pain—Delavirdine—acquired immunodeficiency syndrome	0.000164	0.000805	CcSEcCtD
Dipyridamole—Gastrointestinal pain—Efavirenz—acquired immunodeficiency syndrome	0.000163	0.000805	CcSEcCtD
Dipyridamole—Asthenia—Zidovudine—acquired immunodeficiency syndrome	0.000163	0.000804	CcSEcCtD
Dipyridamole—Rash—Abacavir—acquired immunodeficiency syndrome	0.000163	0.000801	CcSEcCtD
Dipyridamole—Dermatitis—Abacavir—acquired immunodeficiency syndrome	0.000162	0.0008	CcSEcCtD
Dipyridamole—Oedema—Lamivudine—acquired immunodeficiency syndrome	0.000162	0.0008	CcSEcCtD
Dipyridamole—Anaphylactic shock—Lamivudine—acquired immunodeficiency syndrome	0.000162	0.0008	CcSEcCtD
Dipyridamole—Headache—Abacavir—acquired immunodeficiency syndrome	0.000162	0.000795	CcSEcCtD
Dipyridamole—Musculoskeletal discomfort—Ritonavir—acquired immunodeficiency syndrome	0.000161	0.000793	CcSEcCtD
Dipyridamole—Nausea—Nevirapine—acquired immunodeficiency syndrome	0.000161	0.000793	CcSEcCtD
Dipyridamole—Pruritus—Zidovudine—acquired immunodeficiency syndrome	0.000161	0.000793	CcSEcCtD
Dipyridamole—Shock—Lamivudine—acquired immunodeficiency syndrome	0.00016	0.000787	CcSEcCtD
Dipyridamole—Nervous system disorder—Lamivudine—acquired immunodeficiency syndrome	0.000159	0.000784	CcSEcCtD
Dipyridamole—Hypotension—Saquinavir—acquired immunodeficiency syndrome	0.000159	0.000783	CcSEcCtD
Dipyridamole—Thrombocytopenia—Lamivudine—acquired immunodeficiency syndrome	0.000159	0.000783	CcSEcCtD
Dipyridamole—Paraesthesia—Ritonavir—acquired immunodeficiency syndrome	0.000159	0.000782	CcSEcCtD
Dipyridamole—Urticaria—Efavirenz—acquired immunodeficiency syndrome	0.000159	0.000782	CcSEcCtD
Dipyridamole—Abdominal pain—Efavirenz—acquired immunodeficiency syndrome	0.000158	0.000778	CcSEcCtD
Dipyridamole—Skin disorder—Lamivudine—acquired immunodeficiency syndrome	0.000158	0.000777	CcSEcCtD
Dipyridamole—Dyspnoea—Ritonavir—acquired immunodeficiency syndrome	0.000158	0.000776	CcSEcCtD
Dipyridamole—Feeling abnormal—Delavirdine—acquired immunodeficiency syndrome	0.000158	0.000776	CcSEcCtD
Dipyridamole—Somnolence—Ritonavir—acquired immunodeficiency syndrome	0.000157	0.000774	CcSEcCtD
Dipyridamole—Hyperhidrosis—Lamivudine—acquired immunodeficiency syndrome	0.000157	0.000773	CcSEcCtD
Dipyridamole—Gastrointestinal pain—Delavirdine—acquired immunodeficiency syndrome	0.000156	0.00077	CcSEcCtD
Dipyridamole—Nausea—Nelfinavir—acquired immunodeficiency syndrome	0.000156	0.000768	CcSEcCtD
Dipyridamole—Hypersensitivity—Indinavir—acquired immunodeficiency syndrome	0.000156	0.000768	CcSEcCtD
Dipyridamole—Dyspepsia—Ritonavir—acquired immunodeficiency syndrome	0.000156	0.000767	CcSEcCtD
Dipyridamole—Diarrhoea—Zidovudine—acquired immunodeficiency syndrome	0.000156	0.000766	CcSEcCtD
Dipyridamole—Nausea—Stavudine—acquired immunodeficiency syndrome	0.000155	0.000766	CcSEcCtD
Dipyridamole—Musculoskeletal discomfort—Saquinavir—acquired immunodeficiency syndrome	0.000155	0.000764	CcSEcCtD
Dipyridamole—Nausea—Abacavir—acquired immunodeficiency syndrome	0.000153	0.000754	CcSEcCtD
Dipyridamole—Paraesthesia—Saquinavir—acquired immunodeficiency syndrome	0.000153	0.000753	CcSEcCtD
Dipyridamole—Gastrointestinal disorder—Ritonavir—acquired immunodeficiency syndrome	0.000153	0.000752	CcSEcCtD
Dipyridamole—Fatigue—Ritonavir—acquired immunodeficiency syndrome	0.000153	0.000751	CcSEcCtD
Dipyridamole—Urticaria—Delavirdine—acquired immunodeficiency syndrome	0.000152	0.000748	CcSEcCtD
Dipyridamole—Asthenia—Indinavir—acquired immunodeficiency syndrome	0.000152	0.000747	CcSEcCtD
Dipyridamole—Dyspnoea—Saquinavir—acquired immunodeficiency syndrome	0.000152	0.000747	CcSEcCtD
Dipyridamole—Hypotension—Lamivudine—acquired immunodeficiency syndrome	0.000152	0.000747	CcSEcCtD
Dipyridamole—Somnolence—Saquinavir—acquired immunodeficiency syndrome	0.000151	0.000745	CcSEcCtD
Dipyridamole—Pain—Ritonavir—acquired immunodeficiency syndrome	0.000151	0.000745	CcSEcCtD
Dipyridamole—Abdominal pain—Delavirdine—acquired immunodeficiency syndrome	0.000151	0.000745	CcSEcCtD
Dipyridamole—Dizziness—Zidovudine—acquired immunodeficiency syndrome	0.00015	0.000741	CcSEcCtD
Dipyridamole—Dyspepsia—Saquinavir—acquired immunodeficiency syndrome	0.00015	0.000738	CcSEcCtD
Dipyridamole—Pruritus—Indinavir—acquired immunodeficiency syndrome	0.00015	0.000737	CcSEcCtD
Dipyridamole—Musculoskeletal discomfort—Lamivudine—acquired immunodeficiency syndrome	0.000148	0.000729	CcSEcCtD
Dipyridamole—Hypersensitivity—Efavirenz—acquired immunodeficiency syndrome	0.000147	0.000725	CcSEcCtD
Dipyridamole—Gastrointestinal disorder—Saquinavir—acquired immunodeficiency syndrome	0.000147	0.000724	CcSEcCtD
Dipyridamole—Fatigue—Saquinavir—acquired immunodeficiency syndrome	0.000147	0.000723	CcSEcCtD
Dipyridamole—Paraesthesia—Lamivudine—acquired immunodeficiency syndrome	0.000146	0.000718	CcSEcCtD
Dipyridamole—Feeling abnormal—Ritonavir—acquired immunodeficiency syndrome	0.000146	0.000718	CcSEcCtD
Dipyridamole—Pain—Saquinavir—acquired immunodeficiency syndrome	0.000146	0.000717	CcSEcCtD
Dipyridamole—Dyspnoea—Lamivudine—acquired immunodeficiency syndrome	0.000145	0.000713	CcSEcCtD
Dipyridamole—Diarrhoea—Indinavir—acquired immunodeficiency syndrome	0.000145	0.000713	CcSEcCtD
Dipyridamole—Vomiting—Zidovudine—acquired immunodeficiency syndrome	0.000145	0.000712	CcSEcCtD
Dipyridamole—Gastrointestinal pain—Ritonavir—acquired immunodeficiency syndrome	0.000145	0.000712	CcSEcCtD
Dipyridamole—Somnolence—Lamivudine—acquired immunodeficiency syndrome	0.000144	0.000711	CcSEcCtD
Dipyridamole—Rash—Zidovudine—acquired immunodeficiency syndrome	0.000143	0.000706	CcSEcCtD
Dipyridamole—Asthenia—Efavirenz—acquired immunodeficiency syndrome	0.000143	0.000706	CcSEcCtD
Dipyridamole—Dermatitis—Zidovudine—acquired immunodeficiency syndrome	0.000143	0.000706	CcSEcCtD
Dipyridamole—Dyspepsia—Lamivudine—acquired immunodeficiency syndrome	0.000143	0.000704	CcSEcCtD
Dipyridamole—Headache—Zidovudine—acquired immunodeficiency syndrome	0.000143	0.000702	CcSEcCtD
Dipyridamole—Pruritus—Efavirenz—acquired immunodeficiency syndrome	0.000141	0.000696	CcSEcCtD
Dipyridamole—Hypersensitivity—Delavirdine—acquired immunodeficiency syndrome	0.000141	0.000694	CcSEcCtD
Dipyridamole—Urticaria—Ritonavir—acquired immunodeficiency syndrome	0.000141	0.000692	CcSEcCtD
Dipyridamole—Feeling abnormal—Saquinavir—acquired immunodeficiency syndrome	0.00014	0.000691	CcSEcCtD
Dipyridamole—Gastrointestinal disorder—Lamivudine—acquired immunodeficiency syndrome	0.00014	0.00069	CcSEcCtD
Dipyridamole—Fatigue—Lamivudine—acquired immunodeficiency syndrome	0.00014	0.000689	CcSEcCtD
Dipyridamole—Dizziness—Indinavir—acquired immunodeficiency syndrome	0.00014	0.000689	CcSEcCtD
Dipyridamole—Abdominal pain—Ritonavir—acquired immunodeficiency syndrome	0.00014	0.000688	CcSEcCtD
Dipyridamole—Gastrointestinal pain—Saquinavir—acquired immunodeficiency syndrome	0.000139	0.000685	CcSEcCtD
Dipyridamole—Pain—Lamivudine—acquired immunodeficiency syndrome	0.000139	0.000684	CcSEcCtD
Dipyridamole—Asthenia—Delavirdine—acquired immunodeficiency syndrome	0.000137	0.000676	CcSEcCtD
Dipyridamole—Diarrhoea—Efavirenz—acquired immunodeficiency syndrome	0.000137	0.000673	CcSEcCtD
Dipyridamole—Pruritus—Delavirdine—acquired immunodeficiency syndrome	0.000135	0.000666	CcSEcCtD
Dipyridamole—Urticaria—Saquinavir—acquired immunodeficiency syndrome	0.000135	0.000666	CcSEcCtD
Dipyridamole—Nausea—Zidovudine—acquired immunodeficiency syndrome	0.000135	0.000665	CcSEcCtD
Dipyridamole—Abdominal pain—Saquinavir—acquired immunodeficiency syndrome	0.000135	0.000663	CcSEcCtD
Dipyridamole—Vomiting—Indinavir—acquired immunodeficiency syndrome	0.000135	0.000662	CcSEcCtD
Dipyridamole—Feeling abnormal—Lamivudine—acquired immunodeficiency syndrome	0.000134	0.000659	CcSEcCtD
Dipyridamole—Rash—Indinavir—acquired immunodeficiency syndrome	0.000133	0.000657	CcSEcCtD
Dipyridamole—Dermatitis—Indinavir—acquired immunodeficiency syndrome	0.000133	0.000656	CcSEcCtD
Dipyridamole—Gastrointestinal pain—Lamivudine—acquired immunodeficiency syndrome	0.000133	0.000654	CcSEcCtD
Dipyridamole—Headache—Indinavir—acquired immunodeficiency syndrome	0.000133	0.000653	CcSEcCtD
Dipyridamole—Dizziness—Efavirenz—acquired immunodeficiency syndrome	0.000132	0.000651	CcSEcCtD
Dipyridamole—Diarrhoea—Delavirdine—acquired immunodeficiency syndrome	0.000131	0.000644	CcSEcCtD
Dipyridamole—Hypersensitivity—Ritonavir—acquired immunodeficiency syndrome	0.00013	0.000642	CcSEcCtD
Dipyridamole—Urticaria—Lamivudine—acquired immunodeficiency syndrome	0.000129	0.000635	CcSEcCtD
Dipyridamole—Abdominal pain—Lamivudine—acquired immunodeficiency syndrome	0.000128	0.000632	CcSEcCtD
Dipyridamole—Vomiting—Efavirenz—acquired immunodeficiency syndrome	0.000127	0.000626	CcSEcCtD
Dipyridamole—Asthenia—Ritonavir—acquired immunodeficiency syndrome	0.000127	0.000625	CcSEcCtD
Dipyridamole—Dizziness—Delavirdine—acquired immunodeficiency syndrome	0.000126	0.000623	CcSEcCtD
Dipyridamole—ABCB1—lymphoid tissue—acquired immunodeficiency syndrome	0.000126	0.00109	CbGeAlD
Dipyridamole—Rash—Efavirenz—acquired immunodeficiency syndrome	0.000126	0.000621	CcSEcCtD
Dipyridamole—Dermatitis—Efavirenz—acquired immunodeficiency syndrome	0.000126	0.00062	CcSEcCtD
Dipyridamole—Nausea—Indinavir—acquired immunodeficiency syndrome	0.000126	0.000619	CcSEcCtD
Dipyridamole—Hypersensitivity—Saquinavir—acquired immunodeficiency syndrome	0.000125	0.000618	CcSEcCtD
Dipyridamole—Headache—Efavirenz—acquired immunodeficiency syndrome	0.000125	0.000617	CcSEcCtD
Dipyridamole—Pruritus—Ritonavir—acquired immunodeficiency syndrome	0.000125	0.000616	CcSEcCtD
Dipyridamole—ABCB1—digestive system—acquired immunodeficiency syndrome	0.000125	0.00108	CbGeAlD
Dipyridamole—Asthenia—Saquinavir—acquired immunodeficiency syndrome	0.000122	0.000601	CcSEcCtD
Dipyridamole—Vomiting—Delavirdine—acquired immunodeficiency syndrome	0.000122	0.000599	CcSEcCtD
Dipyridamole—Diarrhoea—Ritonavir—acquired immunodeficiency syndrome	0.000121	0.000596	CcSEcCtD
Dipyridamole—Rash—Delavirdine—acquired immunodeficiency syndrome	0.000121	0.000594	CcSEcCtD
Dipyridamole—Dermatitis—Delavirdine—acquired immunodeficiency syndrome	0.00012	0.000593	CcSEcCtD
Dipyridamole—Pruritus—Saquinavir—acquired immunodeficiency syndrome	0.00012	0.000593	CcSEcCtD
Dipyridamole—Headache—Delavirdine—acquired immunodeficiency syndrome	0.00012	0.00059	CcSEcCtD
Dipyridamole—Hypersensitivity—Lamivudine—acquired immunodeficiency syndrome	0.00012	0.000589	CcSEcCtD
Dipyridamole—ABCB1—blood—acquired immunodeficiency syndrome	0.000119	0.00103	CbGeAlD
Dipyridamole—Nausea—Efavirenz—acquired immunodeficiency syndrome	0.000119	0.000585	CcSEcCtD
Dipyridamole—Dizziness—Ritonavir—acquired immunodeficiency syndrome	0.000117	0.000576	CcSEcCtD
Dipyridamole—Asthenia—Lamivudine—acquired immunodeficiency syndrome	0.000117	0.000574	CcSEcCtD
Dipyridamole—Diarrhoea—Saquinavir—acquired immunodeficiency syndrome	0.000116	0.000574	CcSEcCtD
Dipyridamole—ABCB1—bone marrow—acquired immunodeficiency syndrome	0.000115	0.000994	CbGeAlD
Dipyridamole—Pruritus—Lamivudine—acquired immunodeficiency syndrome	0.000115	0.000566	CcSEcCtD
Dipyridamole—ABCB1—spinal cord—acquired immunodeficiency syndrome	0.000115	0.000989	CbGeAlD
Dipyridamole—Nausea—Delavirdine—acquired immunodeficiency syndrome	0.000114	0.000559	CcSEcCtD
Dipyridamole—Dizziness—Saquinavir—acquired immunodeficiency syndrome	0.000113	0.000554	CcSEcCtD
Dipyridamole—Vomiting—Ritonavir—acquired immunodeficiency syndrome	0.000112	0.000554	CcSEcCtD
Dipyridamole—Rash—Ritonavir—acquired immunodeficiency syndrome	0.000112	0.000549	CcSEcCtD
Dipyridamole—Dermatitis—Ritonavir—acquired immunodeficiency syndrome	0.000111	0.000549	CcSEcCtD
Dipyridamole—Diarrhoea—Lamivudine—acquired immunodeficiency syndrome	0.000111	0.000547	CcSEcCtD
Dipyridamole—Headache—Ritonavir—acquired immunodeficiency syndrome	0.000111	0.000546	CcSEcCtD
Dipyridamole—ABCB1—vagina—acquired immunodeficiency syndrome	0.00011	0.000952	CbGeAlD
Dipyridamole—Vomiting—Saquinavir—acquired immunodeficiency syndrome	0.000108	0.000533	CcSEcCtD
Dipyridamole—Dizziness—Lamivudine—acquired immunodeficiency syndrome	0.000107	0.000529	CcSEcCtD
Dipyridamole—Rash—Saquinavir—acquired immunodeficiency syndrome	0.000107	0.000529	CcSEcCtD
Dipyridamole—Dermatitis—Saquinavir—acquired immunodeficiency syndrome	0.000107	0.000528	CcSEcCtD
Dipyridamole—Headache—Saquinavir—acquired immunodeficiency syndrome	0.000107	0.000525	CcSEcCtD
Dipyridamole—Nausea—Ritonavir—acquired immunodeficiency syndrome	0.000105	0.000517	CcSEcCtD
Dipyridamole—ABCB1—lung—acquired immunodeficiency syndrome	0.000104	0.0009	CbGeAlD
Dipyridamole—Vomiting—Lamivudine—acquired immunodeficiency syndrome	0.000103	0.000508	CcSEcCtD
Dipyridamole—Rash—Lamivudine—acquired immunodeficiency syndrome	0.000102	0.000504	CcSEcCtD
Dipyridamole—Dermatitis—Lamivudine—acquired immunodeficiency syndrome	0.000102	0.000504	CcSEcCtD
Dipyridamole—Headache—Lamivudine—acquired immunodeficiency syndrome	0.000102	0.000501	CcSEcCtD
Dipyridamole—Nausea—Saquinavir—acquired immunodeficiency syndrome	0.000101	0.000498	CcSEcCtD
Dipyridamole—ABCB1—nervous system—acquired immunodeficiency syndrome	9.65e-05	0.000834	CbGeAlD
Dipyridamole—Nausea—Lamivudine—acquired immunodeficiency syndrome	9.65e-05	0.000475	CcSEcCtD
Dipyridamole—ABCB1—central nervous system—acquired immunodeficiency syndrome	9.29e-05	0.000802	CbGeAlD
Dipyridamole—ABCB1—brain—acquired immunodeficiency syndrome	7.38e-05	0.000637	CbGeAlD
Dipyridamole—ABCB1—lymph node—acquired immunodeficiency syndrome	7.13e-05	0.000616	CbGeAlD
Dipyridamole—PDE1A—DAP12 signaling—IL6—acquired immunodeficiency syndrome	4.79e-05	0.000944	CbGpPWpGaD
Dipyridamole—PDE3B—Hemostasis—ALB—acquired immunodeficiency syndrome	4.77e-05	0.000939	CbGpPWpGaD
Dipyridamole—PDE8A—Signaling Pathways—CCR5—acquired immunodeficiency syndrome	4.75e-05	0.000935	CbGpPWpGaD
Dipyridamole—PDE8B—Signaling Pathways—CCR5—acquired immunodeficiency syndrome	4.75e-05	0.000935	CbGpPWpGaD
Dipyridamole—PDE1B—Downstream signaling of activated FGFR—IL6—acquired immunodeficiency syndrome	4.73e-05	0.000932	CbGpPWpGaD
Dipyridamole—PDE7B—Signaling Pathways—CCL5—acquired immunodeficiency syndrome	4.7e-05	0.000925	CbGpPWpGaD
Dipyridamole—PDE3B—GPCR downstream signaling—CCL5—acquired immunodeficiency syndrome	4.7e-05	0.000924	CbGpPWpGaD
Dipyridamole—PDE1B—Signaling by GPCR—CCR2—acquired immunodeficiency syndrome	4.67e-05	0.000919	CbGpPWpGaD
Dipyridamole—PDE1A—Immune System—CCR2—acquired immunodeficiency syndrome	4.66e-05	0.000918	CbGpPWpGaD
Dipyridamole—PDE8B—Signaling by GPCR—IL2—acquired immunodeficiency syndrome	4.64e-05	0.000914	CbGpPWpGaD
Dipyridamole—PDE8A—Signaling by GPCR—IL2—acquired immunodeficiency syndrome	4.64e-05	0.000914	CbGpPWpGaD
Dipyridamole—PDE2A—Signaling Pathways—CCR5—acquired immunodeficiency syndrome	4.63e-05	0.000911	CbGpPWpGaD
Dipyridamole—PDE7B—Signaling Pathways—CSF2—acquired immunodeficiency syndrome	4.63e-05	0.000911	CbGpPWpGaD
Dipyridamole—PDE3B—GPCR downstream signaling—CSF2—acquired immunodeficiency syndrome	4.62e-05	0.00091	CbGpPWpGaD
Dipyridamole—PDE7B—GPCR downstream signaling—IL2—acquired immunodeficiency syndrome	4.56e-05	0.000897	CbGpPWpGaD
Dipyridamole—PDE2A—Signaling by GPCR—IL2—acquired immunodeficiency syndrome	4.53e-05	0.000891	CbGpPWpGaD
Dipyridamole—ABCB1—Allograft Rejection—IFNG—acquired immunodeficiency syndrome	4.52e-05	0.000891	CbGpPWpGaD
Dipyridamole—PDE1A—Signaling by FGFR in disease—IL6—acquired immunodeficiency syndrome	4.51e-05	0.000888	CbGpPWpGaD
Dipyridamole—PDE1A—DAP12 interactions—IL6—acquired immunodeficiency syndrome	4.51e-05	0.000888	CbGpPWpGaD
Dipyridamole—PDE1A—Signaling by EGFR—IL6—acquired immunodeficiency syndrome	4.47e-05	0.00088	CbGpPWpGaD
Dipyridamole—PDE1B—Signaling Pathways—CCL4—acquired immunodeficiency syndrome	4.46e-05	0.000879	CbGpPWpGaD
Dipyridamole—ABCC4—Platelet activation, signaling and aggregation—IL2—acquired immunodeficiency syndrome	4.45e-05	0.000877	CbGpPWpGaD
Dipyridamole—PDE1B—Downstream signal transduction—IL6—acquired immunodeficiency syndrome	4.45e-05	0.000876	CbGpPWpGaD
Dipyridamole—PDE1A—Signaling by EGFR in Cancer—IL6—acquired immunodeficiency syndrome	4.43e-05	0.000872	CbGpPWpGaD
Dipyridamole—PDE1B—Signaling by FGFR—IL6—acquired immunodeficiency syndrome	4.43e-05	0.000872	CbGpPWpGaD
Dipyridamole—PDE1A—Signaling by PDGF—IL6—acquired immunodeficiency syndrome	4.41e-05	0.000868	CbGpPWpGaD
Dipyridamole—PDE1B—Signaling by ERBB2—IL6—acquired immunodeficiency syndrome	4.41e-05	0.000867	CbGpPWpGaD
Dipyridamole—PDE4A—GPCR downstream signaling—CCL5—acquired immunodeficiency syndrome	4.4e-05	0.000865	CbGpPWpGaD
Dipyridamole—PDE1B—Signaling by GPCR—CXCR4—acquired immunodeficiency syndrome	4.39e-05	0.000864	CbGpPWpGaD
Dipyridamole—PDE1B—Signaling by GPCR—CXCL12—acquired immunodeficiency syndrome	4.39e-05	0.000864	CbGpPWpGaD
Dipyridamole—PDE1B—DAP12 signaling—IL6—acquired immunodeficiency syndrome	4.38e-05	0.000863	CbGpPWpGaD
Dipyridamole—PDE11A—Signaling Pathways—CCL5—acquired immunodeficiency syndrome	4.37e-05	0.00086	CbGpPWpGaD
Dipyridamole—PDE7A—Signaling Pathways—CCL5—acquired immunodeficiency syndrome	4.37e-05	0.00086	CbGpPWpGaD
Dipyridamole—ABCC4—Hemostasis—CSF2—acquired immunodeficiency syndrome	4.34e-05	0.000855	CbGpPWpGaD
Dipyridamole—PDE3A—Hemostasis—ALB—acquired immunodeficiency syndrome	4.34e-05	0.000855	CbGpPWpGaD
Dipyridamole—PDE4A—GPCR downstream signaling—CSF2—acquired immunodeficiency syndrome	4.33e-05	0.000852	CbGpPWpGaD
Dipyridamole—PDE11A—Signaling Pathways—CSF2—acquired immunodeficiency syndrome	4.3e-05	0.000847	CbGpPWpGaD
Dipyridamole—PDE7A—Signaling Pathways—CSF2—acquired immunodeficiency syndrome	4.3e-05	0.000847	CbGpPWpGaD
Dipyridamole—PDE3A—GPCR downstream signaling—CCL5—acquired immunodeficiency syndrome	4.28e-05	0.000842	CbGpPWpGaD
Dipyridamole—PDE1B—Immune System—CCR2—acquired immunodeficiency syndrome	4.27e-05	0.00084	CbGpPWpGaD
Dipyridamole—PDE3B—Signaling by GPCR—CCL5—acquired immunodeficiency syndrome	4.26e-05	0.000839	CbGpPWpGaD
Dipyridamole—PDE11A—GPCR downstream signaling—IL2—acquired immunodeficiency syndrome	4.24e-05	0.000834	CbGpPWpGaD
Dipyridamole—PDE7A—GPCR downstream signaling—IL2—acquired immunodeficiency syndrome	4.24e-05	0.000834	CbGpPWpGaD
Dipyridamole—PDE7B—Signaling Pathways—CCR5—acquired immunodeficiency syndrome	4.23e-05	0.000833	CbGpPWpGaD
Dipyridamole—PDE3B—GPCR downstream signaling—CCR5—acquired immunodeficiency syndrome	4.23e-05	0.000833	CbGpPWpGaD
Dipyridamole—PDE3A—GPCR downstream signaling—CSF2—acquired immunodeficiency syndrome	4.21e-05	0.000829	CbGpPWpGaD
Dipyridamole—PDE3B—Signaling by GPCR—CSF2—acquired immunodeficiency syndrome	4.2e-05	0.000827	CbGpPWpGaD
Dipyridamole—PDE1A—Immune System—IFNA1—acquired immunodeficiency syndrome	4.2e-05	0.000827	CbGpPWpGaD
Dipyridamole—PDE7B—Signaling by GPCR—IL2—acquired immunodeficiency syndrome	4.14e-05	0.000815	CbGpPWpGaD
Dipyridamole—PDE1B—DAP12 interactions—IL6—acquired immunodeficiency syndrome	4.13e-05	0.000812	CbGpPWpGaD
Dipyridamole—PDE1B—Signaling by FGFR in disease—IL6—acquired immunodeficiency syndrome	4.13e-05	0.000812	CbGpPWpGaD
Dipyridamole—PDE1B—Signaling by EGFR—IL6—acquired immunodeficiency syndrome	4.09e-05	0.000805	CbGpPWpGaD
Dipyridamole—PDE1A—Hemostasis—ALB—acquired immunodeficiency syndrome	4.08e-05	0.000804	CbGpPWpGaD
Dipyridamole—PDE1A—Immune System—CD79A—acquired immunodeficiency syndrome	4.08e-05	0.000802	CbGpPWpGaD
Dipyridamole—PDE1B—Signaling by EGFR in Cancer—IL6—acquired immunodeficiency syndrome	4.05e-05	0.000798	CbGpPWpGaD
Dipyridamole—PDE1C—Signaling Pathways—CCL5—acquired immunodeficiency syndrome	4.05e-05	0.000797	CbGpPWpGaD
Dipyridamole—ABCC5—Disease—CXCR4—acquired immunodeficiency syndrome	4.05e-05	0.000797	CbGpPWpGaD
Dipyridamole—PDE1A—Disease—CXCR4—acquired immunodeficiency syndrome	4.05e-05	0.000797	CbGpPWpGaD
Dipyridamole—PDE1B—Signaling by PDGF—IL6—acquired immunodeficiency syndrome	4.03e-05	0.000794	CbGpPWpGaD
Dipyridamole—ABCB1—Allograft Rejection—IL2—acquired immunodeficiency syndrome	4.02e-05	0.000791	CbGpPWpGaD
Dipyridamole—PDE1A—GPCR downstream signaling—CCL5—acquired immunodeficiency syndrome	4.02e-05	0.000791	CbGpPWpGaD
Dipyridamole—PDE1A—NGF signalling via TRKA from the plasma membrane—IL6—acquired immunodeficiency syndrome	3.99e-05	0.000786	CbGpPWpGaD
Dipyridamole—PDE6G—Signaling Pathways—CCL5—acquired immunodeficiency syndrome	3.99e-05	0.000786	CbGpPWpGaD
Dipyridamole—PDE4A—Signaling by GPCR—CCL5—acquired immunodeficiency syndrome	3.99e-05	0.000786	CbGpPWpGaD
Dipyridamole—PDE1C—Signaling Pathways—CSF2—acquired immunodeficiency syndrome	3.99e-05	0.000785	CbGpPWpGaD
Dipyridamole—PDE4A—GPCR downstream signaling—CCR5—acquired immunodeficiency syndrome	3.96e-05	0.00078	CbGpPWpGaD
Dipyridamole—PDE1A—GPCR downstream signaling—CSF2—acquired immunodeficiency syndrome	3.96e-05	0.00078	CbGpPWpGaD
Dipyridamole—PDE11A—Signaling Pathways—CCR5—acquired immunodeficiency syndrome	3.93e-05	0.000774	CbGpPWpGaD
Dipyridamole—PDE7A—Signaling Pathways—CCR5—acquired immunodeficiency syndrome	3.93e-05	0.000774	CbGpPWpGaD
Dipyridamole—PDE6G—Signaling Pathways—CSF2—acquired immunodeficiency syndrome	3.93e-05	0.000774	CbGpPWpGaD
Dipyridamole—PDE4A—Signaling by GPCR—CSF2—acquired immunodeficiency syndrome	3.93e-05	0.000774	CbGpPWpGaD
Dipyridamole—PDE3B—Signaling Pathways—CCL3—acquired immunodeficiency syndrome	3.89e-05	0.000766	CbGpPWpGaD
Dipyridamole—PDE10A—Signaling Pathways—CCL5—acquired immunodeficiency syndrome	3.89e-05	0.000766	CbGpPWpGaD
Dipyridamole—PDE3A—Signaling by GPCR—CCL5—acquired immunodeficiency syndrome	3.88e-05	0.000764	CbGpPWpGaD
Dipyridamole—PDE3B—Hemostasis—IL2—acquired immunodeficiency syndrome	3.87e-05	0.000761	CbGpPWpGaD
Dipyridamole—PDE3A—GPCR downstream signaling—CCR5—acquired immunodeficiency syndrome	3.85e-05	0.000758	CbGpPWpGaD
Dipyridamole—PDE11A—Signaling by GPCR—IL2—acquired immunodeficiency syndrome	3.85e-05	0.000757	CbGpPWpGaD
Dipyridamole—PDE7A—Signaling by GPCR—IL2—acquired immunodeficiency syndrome	3.85e-05	0.000757	CbGpPWpGaD
Dipyridamole—PDE3B—Signaling by GPCR—CCR5—acquired immunodeficiency syndrome	3.84e-05	0.000756	CbGpPWpGaD
Dipyridamole—PDE1B—Immune System—IFNA1—acquired immunodeficiency syndrome	3.84e-05	0.000756	CbGpPWpGaD
Dipyridamole—PDE10A—Signaling Pathways—CSF2—acquired immunodeficiency syndrome	3.83e-05	0.000755	CbGpPWpGaD
Dipyridamole—PDE3A—Signaling by GPCR—CSF2—acquired immunodeficiency syndrome	3.83e-05	0.000753	CbGpPWpGaD
Dipyridamole—PDE10A—GPCR downstream signaling—IL2—acquired immunodeficiency syndrome	3.78e-05	0.000743	CbGpPWpGaD
Dipyridamole—PDE1B—Hemostasis—ALB—acquired immunodeficiency syndrome	3.74e-05	0.000735	CbGpPWpGaD
Dipyridamole—PDE1B—Immune System—CD79A—acquired immunodeficiency syndrome	3.73e-05	0.000734	CbGpPWpGaD
Dipyridamole—PDE1B—Disease—CXCR4—acquired immunodeficiency syndrome	3.7e-05	0.000729	CbGpPWpGaD
Dipyridamole—PDE1B—GPCR downstream signaling—CCL5—acquired immunodeficiency syndrome	3.68e-05	0.000724	CbGpPWpGaD
Dipyridamole—PDE1C—Immune System—IFNG—acquired immunodeficiency syndrome	3.67e-05	0.000722	CbGpPWpGaD
Dipyridamole—PDE1B—NGF signalling via TRKA from the plasma membrane—IL6—acquired immunodeficiency syndrome	3.65e-05	0.000719	CbGpPWpGaD
Dipyridamole—PDE1A—Signaling by GPCR—CCL5—acquired immunodeficiency syndrome	3.65e-05	0.000719	CbGpPWpGaD
Dipyridamole—PDE1C—Signaling Pathways—CCR5—acquired immunodeficiency syndrome	3.65e-05	0.000718	CbGpPWpGaD
Dipyridamole—PDE4A—Signaling Pathways—CCL3—acquired immunodeficiency syndrome	3.65e-05	0.000718	CbGpPWpGaD
Dipyridamole—PDE1B—GPCR downstream signaling—CSF2—acquired immunodeficiency syndrome	3.62e-05	0.000713	CbGpPWpGaD
Dipyridamole—PDE1A—GPCR downstream signaling—CCR5—acquired immunodeficiency syndrome	3.62e-05	0.000713	CbGpPWpGaD
Dipyridamole—PDE6G—Signaling Pathways—CCR5—acquired immunodeficiency syndrome	3.6e-05	0.000708	CbGpPWpGaD
Dipyridamole—PDE1A—Signaling by GPCR—CSF2—acquired immunodeficiency syndrome	3.6e-05	0.000708	CbGpPWpGaD
Dipyridamole—PDE4A—Signaling by GPCR—CCR5—acquired immunodeficiency syndrome	3.6e-05	0.000708	CbGpPWpGaD
Dipyridamole—PDE1C—Signaling by GPCR—IL2—acquired immunodeficiency syndrome	3.57e-05	0.000702	CbGpPWpGaD
Dipyridamole—PDE3A—Signaling Pathways—CCL3—acquired immunodeficiency syndrome	3.55e-05	0.000698	CbGpPWpGaD
Dipyridamole—PDE1C—Immune System—CD4—acquired immunodeficiency syndrome	3.54e-05	0.000697	CbGpPWpGaD
Dipyridamole—ABCC5—Transmembrane transport of small molecules—ALB—acquired immunodeficiency syndrome	3.54e-05	0.000696	CbGpPWpGaD
Dipyridamole—PDE3A—Hemostasis—IL2—acquired immunodeficiency syndrome	3.52e-05	0.000693	CbGpPWpGaD
Dipyridamole—PDE3B—Signaling Pathways—CCR2—acquired immunodeficiency syndrome	3.52e-05	0.000693	CbGpPWpGaD
Dipyridamole—PDE10A—Signaling Pathways—CCR5—acquired immunodeficiency syndrome	3.51e-05	0.00069	CbGpPWpGaD
Dipyridamole—PDE3A—Signaling by GPCR—CCR5—acquired immunodeficiency syndrome	3.5e-05	0.000689	CbGpPWpGaD
Dipyridamole—PDE10A—Signaling by GPCR—IL2—acquired immunodeficiency syndrome	3.43e-05	0.000675	CbGpPWpGaD
Dipyridamole—PDE1B—Signaling by GPCR—CCL5—acquired immunodeficiency syndrome	3.34e-05	0.000657	CbGpPWpGaD
Dipyridamole—PDE1A—Signaling Pathways—CCL3—acquired immunodeficiency syndrome	3.33e-05	0.000656	CbGpPWpGaD
Dipyridamole—PDE1A—Immune System—CD40LG—acquired immunodeficiency syndrome	3.32e-05	0.000654	CbGpPWpGaD
Dipyridamole—PDE1B—GPCR downstream signaling—CCR5—acquired immunodeficiency syndrome	3.31e-05	0.000652	CbGpPWpGaD
Dipyridamole—PDE1A—Hemostasis—IL2—acquired immunodeficiency syndrome	3.31e-05	0.000652	CbGpPWpGaD
Dipyridamole—PDE3B—Signaling Pathways—CXCL12—acquired immunodeficiency syndrome	3.31e-05	0.000652	CbGpPWpGaD
Dipyridamole—PDE3B—Signaling Pathways—CXCR4—acquired immunodeficiency syndrome	3.31e-05	0.000652	CbGpPWpGaD
Dipyridamole—PDE4A—Signaling Pathways—CCR2—acquired immunodeficiency syndrome	3.3e-05	0.000649	CbGpPWpGaD
Dipyridamole—PDE1C—Innate Immune System—IL6—acquired immunodeficiency syndrome	3.29e-05	0.000648	CbGpPWpGaD
Dipyridamole—PDE1A—Signaling by GPCR—CCR5—acquired immunodeficiency syndrome	3.29e-05	0.000647	CbGpPWpGaD
Dipyridamole—PDE1B—Signaling by GPCR—CSF2—acquired immunodeficiency syndrome	3.29e-05	0.000647	CbGpPWpGaD
Dipyridamole—PDE1A—Immune System—CD8A—acquired immunodeficiency syndrome	3.29e-05	0.000647	CbGpPWpGaD
Dipyridamole—PDE1A—Immune System—CSF2—acquired immunodeficiency syndrome	3.29e-05	0.000647	CbGpPWpGaD
Dipyridamole—PDE1C—Disease—CD4—acquired immunodeficiency syndrome	3.27e-05	0.000644	CbGpPWpGaD
Dipyridamole—PDE1C—Immune System—IL2—acquired immunodeficiency syndrome	3.26e-05	0.000642	CbGpPWpGaD
Dipyridamole—PDE1A—Innate Immune System—CD4—acquired immunodeficiency syndrome	3.24e-05	0.000638	CbGpPWpGaD
Dipyridamole—PDE6G—Disease—CD4—acquired immunodeficiency syndrome	3.23e-05	0.000635	CbGpPWpGaD
Dipyridamole—PDE6A—Signaling Pathways—IL2—acquired immunodeficiency syndrome	3.23e-05	0.000635	CbGpPWpGaD
Dipyridamole—PDE6B—Signaling Pathways—IL2—acquired immunodeficiency syndrome	3.23e-05	0.000635	CbGpPWpGaD
Dipyridamole—PDE3A—Signaling Pathways—CCR2—acquired immunodeficiency syndrome	3.21e-05	0.000631	CbGpPWpGaD
Dipyridamole—PDE1A—Immune System—HLA-B—acquired immunodeficiency syndrome	3.16e-05	0.000622	CbGpPWpGaD
Dipyridamole—PDE4A—Signaling Pathways—CXCR4—acquired immunodeficiency syndrome	3.1e-05	0.00061	CbGpPWpGaD
Dipyridamole—PDE4A—Signaling Pathways—CXCL12—acquired immunodeficiency syndrome	3.1e-05	0.00061	CbGpPWpGaD
Dipyridamole—PDE1A—Signaling by NGF—IL6—acquired immunodeficiency syndrome	3.07e-05	0.000605	CbGpPWpGaD
Dipyridamole—PDE1B—Signaling Pathways—CCL3—acquired immunodeficiency syndrome	3.05e-05	0.0006	CbGpPWpGaD
Dipyridamole—PDE1B—Immune System—CD40LG—acquired immunodeficiency syndrome	3.04e-05	0.000598	CbGpPWpGaD
Dipyridamole—PDE1B—Hemostasis—IL2—acquired immunodeficiency syndrome	3.03e-05	0.000596	CbGpPWpGaD
Dipyridamole—PDE3A—Signaling Pathways—CXCR4—acquired immunodeficiency syndrome	3.02e-05	0.000594	CbGpPWpGaD
Dipyridamole—PDE1A—Signaling Pathways—CCR2—acquired immunodeficiency syndrome	3.02e-05	0.000594	CbGpPWpGaD
Dipyridamole—PDE3A—Signaling Pathways—CXCL12—acquired immunodeficiency syndrome	3.02e-05	0.000594	CbGpPWpGaD
Dipyridamole—PDE1B—Signaling by GPCR—CCR5—acquired immunodeficiency syndrome	3.01e-05	0.000592	CbGpPWpGaD
Dipyridamole—PDE1B—Immune System—CD8A—acquired immunodeficiency syndrome	3.01e-05	0.000592	CbGpPWpGaD
Dipyridamole—PDE1B—Immune System—CSF2—acquired immunodeficiency syndrome	3.01e-05	0.000592	CbGpPWpGaD
Dipyridamole—PDE1B—Innate Immune System—CD4—acquired immunodeficiency syndrome	2.96e-05	0.000583	CbGpPWpGaD
Dipyridamole—ABCB1—Allograft Rejection—TNF—acquired immunodeficiency syndrome	2.93e-05	0.000576	CbGpPWpGaD
Dipyridamole—PDE1B—Immune System—HLA-B—acquired immunodeficiency syndrome	2.89e-05	0.000569	CbGpPWpGaD
Dipyridamole—PDE1A—Signaling Pathways—CXCR4—acquired immunodeficiency syndrome	2.84e-05	0.000558	CbGpPWpGaD
Dipyridamole—PDE1A—Signaling Pathways—CXCL12—acquired immunodeficiency syndrome	2.84e-05	0.000558	CbGpPWpGaD
Dipyridamole—ABCC4—Hemostasis—ALB—acquired immunodeficiency syndrome	2.83e-05	0.000557	CbGpPWpGaD
Dipyridamole—PDE1B—Signaling by NGF—IL6—acquired immunodeficiency syndrome	2.81e-05	0.000553	CbGpPWpGaD
Dipyridamole—PDE1A—Disease—CCR5—acquired immunodeficiency syndrome	2.77e-05	0.000546	CbGpPWpGaD
Dipyridamole—ABCC5—Disease—CCR5—acquired immunodeficiency syndrome	2.77e-05	0.000546	CbGpPWpGaD
Dipyridamole—PDE1B—Signaling Pathways—CCR2—acquired immunodeficiency syndrome	2.76e-05	0.000543	CbGpPWpGaD
Dipyridamole—PDE8A—Signaling Pathways—IL2—acquired immunodeficiency syndrome	2.74e-05	0.00054	CbGpPWpGaD
Dipyridamole—PDE8B—Signaling Pathways—IL2—acquired immunodeficiency syndrome	2.74e-05	0.00054	CbGpPWpGaD
Dipyridamole—PDE8B—Signaling by GPCR—IL6—acquired immunodeficiency syndrome	2.73e-05	0.000537	CbGpPWpGaD
Dipyridamole—PDE8A—Signaling by GPCR—IL6—acquired immunodeficiency syndrome	2.73e-05	0.000537	CbGpPWpGaD
Dipyridamole—PDE6A—Disease—IL6—acquired immunodeficiency syndrome	2.71e-05	0.000533	CbGpPWpGaD
Dipyridamole—PDE6B—Disease—IL6—acquired immunodeficiency syndrome	2.71e-05	0.000533	CbGpPWpGaD
Dipyridamole—PDE2A—Signaling Pathways—IL2—acquired immunodeficiency syndrome	2.67e-05	0.000526	CbGpPWpGaD
Dipyridamole—PDE2A—Signaling by GPCR—IL6—acquired immunodeficiency syndrome	2.66e-05	0.000524	CbGpPWpGaD
Dipyridamole—ABCB1—Metabolism—TAT—acquired immunodeficiency syndrome	2.61e-05	0.000514	CbGpPWpGaD
Dipyridamole—PDE1B—Signaling Pathways—CXCL12—acquired immunodeficiency syndrome	2.59e-05	0.00051	CbGpPWpGaD
Dipyridamole—PDE1B—Signaling Pathways—CXCR4—acquired immunodeficiency syndrome	2.59e-05	0.00051	CbGpPWpGaD
Dipyridamole—PDE1B—Disease—CCR5—acquired immunodeficiency syndrome	2.54e-05	0.0005	CbGpPWpGaD
Dipyridamole—PDE3B—Signaling Pathways—CCL5—acquired immunodeficiency syndrome	2.52e-05	0.000496	CbGpPWpGaD
Dipyridamole—PDE3B—Signaling Pathways—CSF2—acquired immunodeficiency syndrome	2.48e-05	0.000488	CbGpPWpGaD
Dipyridamole—ABCC4—Transmembrane transport of small molecules—ALB—acquired immunodeficiency syndrome	2.45e-05	0.000482	CbGpPWpGaD
Dipyridamole—PDE7B—Signaling Pathways—IL2—acquired immunodeficiency syndrome	2.45e-05	0.000481	CbGpPWpGaD
Dipyridamole—PDE3B—GPCR downstream signaling—IL2—acquired immunodeficiency syndrome	2.44e-05	0.000481	CbGpPWpGaD
Dipyridamole—PDE7B—Signaling by GPCR—IL6—acquired immunodeficiency syndrome	2.43e-05	0.000479	CbGpPWpGaD
Dipyridamole—PDE4A—Signaling Pathways—CCL5—acquired immunodeficiency syndrome	2.36e-05	0.000464	CbGpPWpGaD
Dipyridamole—PDE4A—Signaling Pathways—CSF2—acquired immunodeficiency syndrome	2.32e-05	0.000457	CbGpPWpGaD
Dipyridamole—ABCC4—Hemostasis—IL2—acquired immunodeficiency syndrome	2.3e-05	0.000452	CbGpPWpGaD
Dipyridamole—PDE3A—Signaling Pathways—CCL5—acquired immunodeficiency syndrome	2.29e-05	0.000452	CbGpPWpGaD
Dipyridamole—PDE4A—GPCR downstream signaling—IL2—acquired immunodeficiency syndrome	2.29e-05	0.00045	CbGpPWpGaD
Dipyridamole—ADA—Metabolism—ALB—acquired immunodeficiency syndrome	2.28e-05	0.000449	CbGpPWpGaD
Dipyridamole—PDE11A—Signaling Pathways—IL2—acquired immunodeficiency syndrome	2.27e-05	0.000447	CbGpPWpGaD
Dipyridamole—PDE7A—Signaling Pathways—IL2—acquired immunodeficiency syndrome	2.27e-05	0.000447	CbGpPWpGaD
Dipyridamole—PDE3B—Signaling Pathways—CCR5—acquired immunodeficiency syndrome	2.27e-05	0.000447	CbGpPWpGaD
Dipyridamole—PDE11A—Signaling by GPCR—IL6—acquired immunodeficiency syndrome	2.26e-05	0.000445	CbGpPWpGaD
Dipyridamole—PDE7A—Signaling by GPCR—IL6—acquired immunodeficiency syndrome	2.26e-05	0.000445	CbGpPWpGaD
Dipyridamole—PDE3A—Signaling Pathways—CSF2—acquired immunodeficiency syndrome	2.26e-05	0.000445	CbGpPWpGaD
Dipyridamole—PDE3A—GPCR downstream signaling—IL2—acquired immunodeficiency syndrome	2.23e-05	0.000438	CbGpPWpGaD
Dipyridamole—PDE3B—Signaling by GPCR—IL2—acquired immunodeficiency syndrome	2.22e-05	0.000437	CbGpPWpGaD
Dipyridamole—ABCB1—Metabolism—AGPS—acquired immunodeficiency syndrome	2.22e-05	0.000437	CbGpPWpGaD
Dipyridamole—PDE1A—Signaling Pathways—CCL5—acquired immunodeficiency syndrome	2.16e-05	0.000425	CbGpPWpGaD
Dipyridamole—PDE4A—Signaling Pathways—CCR5—acquired immunodeficiency syndrome	2.12e-05	0.000418	CbGpPWpGaD
Dipyridamole—PDE1A—Signaling Pathways—CSF2—acquired immunodeficiency syndrome	2.12e-05	0.000418	CbGpPWpGaD
Dipyridamole—PDE1C—Signaling Pathways—IL2—acquired immunodeficiency syndrome	2.11e-05	0.000415	CbGpPWpGaD
Dipyridamole—PDE1C—Signaling by GPCR—IL6—acquired immunodeficiency syndrome	2.1e-05	0.000413	CbGpPWpGaD
Dipyridamole—PDE1A—GPCR downstream signaling—IL2—acquired immunodeficiency syndrome	2.09e-05	0.000412	CbGpPWpGaD
Dipyridamole—PDE6G—Signaling Pathways—IL2—acquired immunodeficiency syndrome	2.08e-05	0.000409	CbGpPWpGaD
Dipyridamole—PDE4A—Signaling by GPCR—IL2—acquired immunodeficiency syndrome	2.08e-05	0.000409	CbGpPWpGaD
Dipyridamole—PDE3A—Signaling Pathways—CCR5—acquired immunodeficiency syndrome	2.07e-05	0.000407	CbGpPWpGaD
Dipyridamole—PDE10A—Signaling Pathways—IL2—acquired immunodeficiency syndrome	2.03e-05	0.000399	CbGpPWpGaD
Dipyridamole—PDE3A—Signaling by GPCR—IL2—acquired immunodeficiency syndrome	2.02e-05	0.000398	CbGpPWpGaD
Dipyridamole—PDE10A—Signaling by GPCR—IL6—acquired immunodeficiency syndrome	2.02e-05	0.000397	CbGpPWpGaD
Dipyridamole—PDE1B—Signaling Pathways—CCL5—acquired immunodeficiency syndrome	1.97e-05	0.000388	CbGpPWpGaD
Dipyridamole—PDE1A—Immune System—IFNG—acquired immunodeficiency syndrome	1.95e-05	0.000385	CbGpPWpGaD
Dipyridamole—PDE1B—Signaling Pathways—CSF2—acquired immunodeficiency syndrome	1.94e-05	0.000382	CbGpPWpGaD
Dipyridamole—PDE1A—Signaling Pathways—CCR5—acquired immunodeficiency syndrome	1.94e-05	0.000382	CbGpPWpGaD
Dipyridamole—PDE1C—Immune System—IL6—acquired immunodeficiency syndrome	1.92e-05	0.000377	CbGpPWpGaD
Dipyridamole—PDE1B—GPCR downstream signaling—IL2—acquired immunodeficiency syndrome	1.91e-05	0.000377	CbGpPWpGaD
Dipyridamole—PDE1A—Signaling by GPCR—IL2—acquired immunodeficiency syndrome	1.9e-05	0.000374	CbGpPWpGaD
Dipyridamole—PDE6B—Signaling Pathways—IL6—acquired immunodeficiency syndrome	1.9e-05	0.000373	CbGpPWpGaD
Dipyridamole—PDE6A—Signaling Pathways—IL6—acquired immunodeficiency syndrome	1.9e-05	0.000373	CbGpPWpGaD
Dipyridamole—PDE1A—Immune System—CD4—acquired immunodeficiency syndrome	1.89e-05	0.000372	CbGpPWpGaD
Dipyridamole—PDE1B—Immune System—IFNG—acquired immunodeficiency syndrome	1.79e-05	0.000352	CbGpPWpGaD
Dipyridamole—PDE1B—Signaling Pathways—CCR5—acquired immunodeficiency syndrome	1.78e-05	0.00035	CbGpPWpGaD
Dipyridamole—PDE1C—Disease—IL6—acquired immunodeficiency syndrome	1.77e-05	0.000348	CbGpPWpGaD
Dipyridamole—PDE1A—Innate Immune System—IL6—acquired immunodeficiency syndrome	1.75e-05	0.000345	CbGpPWpGaD
Dipyridamole—PDE6G—Disease—IL6—acquired immunodeficiency syndrome	1.75e-05	0.000344	CbGpPWpGaD
Dipyridamole—PDE1A—Disease—CD4—acquired immunodeficiency syndrome	1.74e-05	0.000343	CbGpPWpGaD
Dipyridamole—ABCC5—Disease—CD4—acquired immunodeficiency syndrome	1.74e-05	0.000343	CbGpPWpGaD
Dipyridamole—PDE1B—Signaling by GPCR—IL2—acquired immunodeficiency syndrome	1.74e-05	0.000342	CbGpPWpGaD
Dipyridamole—PDE1A—Immune System—IL2—acquired immunodeficiency syndrome	1.74e-05	0.000342	CbGpPWpGaD
Dipyridamole—PDE1B—Immune System—CD4—acquired immunodeficiency syndrome	1.73e-05	0.00034	CbGpPWpGaD
Dipyridamole—ABCC5—Metabolism—ALB—acquired immunodeficiency syndrome	1.66e-05	0.000326	CbGpPWpGaD
Dipyridamole—PDE8B—Signaling Pathways—IL6—acquired immunodeficiency syndrome	1.61e-05	0.000317	CbGpPWpGaD
Dipyridamole—PDE8A—Signaling Pathways—IL6—acquired immunodeficiency syndrome	1.61e-05	0.000317	CbGpPWpGaD
Dipyridamole—PDE1B—Innate Immune System—IL6—acquired immunodeficiency syndrome	1.6e-05	0.000315	CbGpPWpGaD
Dipyridamole—PDE1B—Disease—CD4—acquired immunodeficiency syndrome	1.59e-05	0.000314	CbGpPWpGaD
Dipyridamole—PDE1B—Immune System—IL2—acquired immunodeficiency syndrome	1.59e-05	0.000313	CbGpPWpGaD
Dipyridamole—PDE2A—Signaling Pathways—IL6—acquired immunodeficiency syndrome	1.57e-05	0.000309	CbGpPWpGaD
Dipyridamole—ABCB1—Integrated Pancreatic Cancer Pathway—TNF—acquired immunodeficiency syndrome	1.45e-05	0.000284	CbGpPWpGaD
Dipyridamole—PDE7B—Signaling Pathways—IL6—acquired immunodeficiency syndrome	1.44e-05	0.000283	CbGpPWpGaD
Dipyridamole—PDE11A—Signaling Pathways—IL6—acquired immunodeficiency syndrome	1.34e-05	0.000263	CbGpPWpGaD
Dipyridamole—PDE7A—Signaling Pathways—IL6—acquired immunodeficiency syndrome	1.34e-05	0.000263	CbGpPWpGaD
Dipyridamole—PDE3B—Signaling Pathways—IL2—acquired immunodeficiency syndrome	1.31e-05	0.000258	CbGpPWpGaD
Dipyridamole—PDE3B—Signaling by GPCR—IL6—acquired immunodeficiency syndrome	1.3e-05	0.000257	CbGpPWpGaD
Dipyridamole—PDE1C—Signaling Pathways—IL6—acquired immunodeficiency syndrome	1.24e-05	0.000244	CbGpPWpGaD
Dipyridamole—PDE4A—Signaling Pathways—IL2—acquired immunodeficiency syndrome	1.23e-05	0.000242	CbGpPWpGaD
Dipyridamole—PDE6G—Signaling Pathways—IL6—acquired immunodeficiency syndrome	1.22e-05	0.000241	CbGpPWpGaD
Dipyridamole—PDE4A—Signaling by GPCR—IL6—acquired immunodeficiency syndrome	1.22e-05	0.00024	CbGpPWpGaD
Dipyridamole—PDE3A—Signaling Pathways—IL2—acquired immunodeficiency syndrome	1.19e-05	0.000235	CbGpPWpGaD
Dipyridamole—PDE10A—Signaling Pathways—IL6—acquired immunodeficiency syndrome	1.19e-05	0.000234	CbGpPWpGaD
Dipyridamole—PDE3A—Signaling by GPCR—IL6—acquired immunodeficiency syndrome	1.19e-05	0.000234	CbGpPWpGaD
Dipyridamole—PDE1A—Signaling Pathways—IL2—acquired immunodeficiency syndrome	1.12e-05	0.000221	CbGpPWpGaD
Dipyridamole—PDE1A—Signaling by GPCR—IL6—acquired immunodeficiency syndrome	1.12e-05	0.00022	CbGpPWpGaD
Dipyridamole—PDE1B—Signaling Pathways—IL2—acquired immunodeficiency syndrome	1.03e-05	0.000202	CbGpPWpGaD
Dipyridamole—PDE1B—Signaling by GPCR—IL6—acquired immunodeficiency syndrome	1.02e-05	0.000201	CbGpPWpGaD
Dipyridamole—PDE1A—Immune System—IL6—acquired immunodeficiency syndrome	1.02e-05	0.000201	CbGpPWpGaD
Dipyridamole—ABCB1—Transmembrane transport of small molecules—ALB—acquired immunodeficiency syndrome	9.72e-06	0.000191	CbGpPWpGaD
Dipyridamole—PDE1A—Disease—IL6—acquired immunodeficiency syndrome	9.42e-06	0.000185	CbGpPWpGaD
Dipyridamole—ABCC5—Disease—IL6—acquired immunodeficiency syndrome	9.42e-06	0.000185	CbGpPWpGaD
Dipyridamole—PDE1B—Immune System—IL6—acquired immunodeficiency syndrome	9.34e-06	0.000184	CbGpPWpGaD
Dipyridamole—PDE1B—Disease—IL6—acquired immunodeficiency syndrome	8.62e-06	0.00017	CbGpPWpGaD
Dipyridamole—PDE3B—Signaling Pathways—IL6—acquired immunodeficiency syndrome	7.71e-06	0.000152	CbGpPWpGaD
Dipyridamole—PDE4A—Signaling Pathways—IL6—acquired immunodeficiency syndrome	7.22e-06	0.000142	CbGpPWpGaD
Dipyridamole—PDE3A—Signaling Pathways—IL6—acquired immunodeficiency syndrome	7.02e-06	0.000138	CbGpPWpGaD
Dipyridamole—PDE1A—Signaling Pathways—IL6—acquired immunodeficiency syndrome	6.6e-06	0.00013	CbGpPWpGaD
Dipyridamole—PDE1B—Signaling Pathways—IL6—acquired immunodeficiency syndrome	6.04e-06	0.000119	CbGpPWpGaD
Dipyridamole—ABCB1—Metabolism—ALB—acquired immunodeficiency syndrome	4.55e-06	8.96e-05	CbGpPWpGaD
